Sanuj Ravindran

President, Chief Executive Officer & Director at PellePharm, Inc.

Sanuj Ravindran

Sanuj Ravindran

President, Chief Executive Officer & Director at PellePharm, Inc.

Overview
Career Highlights

PellePharm, Inc.

RelSci Relationships

1285

Number of Boards

9

Birthday

1972

Age

47

Number of Awards

1

Contact Data
Trying to get in touch with Sanuj Ravindran? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Sanuj Ravindran likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at PellePharm, Inc.

Relationship likelihood: Strong

Co-Founder & Director at PellePharm, Inc.

Relationship likelihood: Strong

Venture Partner at Radius Ventures LLC

Relationship likelihood: Strong

Co-Founder at Bridgebio Pharma LLC

Relationship likelihood: Strong

Chief Human Capital Officer at MyClean, Inc.

Relationship likelihood: Strong

Co-Founder at Radius Ventures LLC

Relationship likelihood: Strong

Treasurer & Director at MyoTherix, Inc.

Relationship likelihood: Strong

Venture Partner at Physic Ventures LLC

Relationship likelihood: Strong

Senior Vice President of Portfolio Management & Corporate Development at Bridgebio Pharma LLC

Relationship likelihood: Strong

Senior Vice President of Asset Acquisition, Operations & Strategy at Bridgebio Pharma LLC

Relationship likelihood: Strong

Paths to Sanuj Ravindran
Potential Connections via
Relationship Science
You
Sanuj Ravindran
President, Chief Executive Officer & Director at PellePharm, Inc.
Education
MBA

The Kellogg School of Management (The Kellogg School or Kellogg) is the business school of Northwestern University in Evanston, Illinois, with additional campuses in downtown Chicago, Illinois and Miami, Florida. Kellogg offers full-time, part-time, and executive programs, and partners with schools in China, France/Singapore, India, Hong Kong, Israel, Germany, Canada, and Thailand.Founded in 1908 in downtown Chicago as a part-time evening program, the school was chartered to educate business leaders with "good moral character.

BA with Honors

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. In 1853 the founders purchased a 379-acre tract of land on the shore of Lake Michigan 12 miles north of Chicago. They established a campus and developed the land near it, naming the surrounding town Evanston in honor of one of the University's founders, John Evans. After completing its first building, its first building in 1855, Northwestern began classes that fall with two faculty members and 10 students. Northwestern has three campuses and a total of 12 Schools and Colleges (one of which is located in South Florida. Two campuses are located on Lake Michigan, a 240-acre campus in Evanston, the first suburb north of Chicago, and a 25-acre campus in Chicago. One campus is located in Doha, Qatar. Northwestern University combines innovative teaching and pioneering research in a highly collaborative environment that transcends traditional academic boundaries. It provides students and faculty exceptional opportunities for intellectual, personal and professional growth in a setting enhanced by the richness of Chicago.

Memberships
Fellow
Current

The Society of Kauffman Fellows is a network of venture capitalists operating at 160 venture firms and corporate venture groups in 26 countries on 6 continents, collectively deploying $50B in venture capital.

Career History
President, Chief Executive Officer & Director
2018 - Current

PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. It also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA.

Chief Executive Officer-in-Residence
2018 - Current

BridgeBio Pharma LLC discovers and develops pharmaceutical drugs for patients with genetic diseases. The firm offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA.

Chief Business Officer
2016 - 2017

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler in 2005 and is headquartered in San Diego, CA.

Boards & Committees
President, Chief Executive Officer & Director
Current

PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. It also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA.

Member, Advisory Board
Current
Member, Board of Directors
Prior

Burrill & Co.'s venture capital activities focus exclusively on life science companies whose technologies and products are applicable across range of life science sub-sectors including: (1) human healthcare therapeutics and diagnostics/devices (2) health/wellness (3) agricultural biotechnology (4) biofuels and (5) industrial biotechnology, biomaterials and bioprocesses. In addition, to sector diversification, the firm also diversifies across investment stage. In general, most of their investments are in the start-up through mezzanine stage. Most of the firm's investments are made in series A and B rounds. They do invest in public entities. Burrill & Co. principally invests in the US and Europe. The firm's professionals usually serve on the board of directors of each portfolio company and, when necessary, assist with operational activities. Investments tend to average from $5 million to $15 million over the life of a company.Burrill & Co.'s private equity investments focus on investments in undervalued small-cap and mid-cap public companies and selected buy-outs and spin-outs from pharmaceutical, biotechnology and other life sciences entities. The firm seeks to acquire significant equity positions often through PIPEs and to optimize opportunities for future equity financing, acquisitions and divestitures.

Member, Editorial Board
Current
Transactions
Details Hidden

aTyr Pharma, Inc. raised money in a private placement transaction

Awards & Honors
Board Certification - American Board of Internal Medicine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sanuj Ravindran. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sanuj Ravindran's profile does not indicate a business or promotional relationship of any kind between RelSci and Sanuj Ravindran.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/sanuj-ravindran-3351657
  • https://relationshipscience.com/person/sanuj-ravindran-3351657